2. Search Result
Search Result
Results for "

psychoactive properties

" in MedChemExpress (MCE) Product Catalog:

9

Inhibitors & Agonists

1

Biochemical Assay Reagents

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W014971
    Tryptamine hydrochloride
    1 Publications Verification

    		 Biochemical Assay Reagents Others
    Tryptamine hydrochloride belongs to the class of indole alkaloids and is a derivative of the amino acid tryptophan. Tryptamine hydrochloride is psychoactive and acts as a neurotransmitter in the body, affecting mood, perception and cognition. In its hydrochloride form, Tryptamine hydrochloride hydrochloride, it is commonly used as a research chemical and as a starting material for the synthesis of other organic compounds. It can also occur naturally in certain plants and animals, including fungi and mammals. Due to the psychoactive properties of Tryptamine hydrochloride and its derivatives, its use and possession are controlled substances in many countries.
    Tryptamine hydrochloride
  • HY-169465
    3-Methyl phencyclidine hydrochloride

    		Drug Derivative Neurological Disease
    3-Methyl phencyclidine hydrochloride is an arylcyclohexylamine with psychoactive properties .
    3-Methyl phencyclidine hydrochloride
  • HY-W753724
    N-Ethyl 2C-B hydrochloride

    		Drug Derivative Neurological Disease
    N-Ethyl 2C-B hydrochloride is a phenethylamine with psychoactive properties .
    N-Ethyl 2C-B hydrochloride
  • HY-169447
    2,3,4-Trimethoxyamphetamine hydrochloride

    		Drug Derivative Neurological Disease
    2,3,4-Trimethoxyamphetamine hydrochloride is an amphetamine with psychoactive properties .
    2,3,4-Trimethoxyamphetamine hydrochloride
  • HY-W775306
    Cannabidivarinic acid

    CBDVA

    		 Cannabinoid Receptor Neurological Disease Inflammation/Immunology
    Cannabidivarinic acid (CBDVA), the carboxylic acid precursor of Cannabidivarin(CBDV), is a non-psychoactive cannabinoid found in Cannabis with anti-inflammatory properties .
    Cannabidivarinic acid
  • HY-168750
    MDMB-FUBICA

    		Cannabinoid Receptor Neurological Disease
    MDMB-FUBICA, a synthetic cannabinoid, is a potent agonist of the cannabinoid receptors with psychoactive properties. MDMB-FUBICA can be used in electronic cigarette .
    MDMB-FUBICA
  • HY-59059
    5-(2-Aminopropyl)indole

    		Monoamine Oxidase Neurological Disease
    5-(2-Aminopropyl)indole is an orally active psychoactive substance, that shows inhibitory activity against monoamine oxidase (MAO) and long-lasting stimulatory properties .
    5-(2-Aminopropyl)indole
  • HY-A0171
    Benzoctamine

    Ba-30803 free base

    		 5-HT Receptor Neurological Disease
    Benzoctamine is an orally active and potent psychoactive agent which possesses tranquillizing properties. Benzoctamine increases the turnover rate of catecholamines. Benzoctamine enhances the [3H]noradrenaline uptake in the rat heart. Benzoctamine also accelerated the disappearance of intracisternally injected [3H]noradrenaline .
    Benzoctamine
  • HY-117087
    K103

    		Phosphatase Cancer
    K103 is an inhibitor discovered from the screen that is an analog of the serotonin antagonist benzazocine. K103 exhibited inhibition of SHIP homologues, labelling it a pan-SHIP1/2 inhibitor, but the molecule had no effect on another 5' inositol phosphatase, OCRL. In line with the "two PIPs hypothesis", the molecule exhibited significant anti-tumour effects against a variety of cell lines, particularly breast cancer cells. Additional studies with K103 revealed that inhibition of SHIP1/2 in multiple myeloma cells resulted in G2/M cell cycle arrest followed by extensive apoptosis via activation of the caspase cascade. K103 fits the commonly used small molecule agent property profile, but while this work was being conducted, it was discovered that K103 caused psychoactive effects in mice, which limited the utility of the molecule in vivo. Therefore, certain synthetic studies were conducted on this tryptamine to identify the features that needed to be present in the molecule to maintain pan-SHIP1/2 inhibition in order to design an inhibitor with favourable pharmacodynamic properties and an improved side effect profile.
    K103

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: